mick Saturday, 05/18/19 05:01:52 PM Re: mick post# 44522 Post # of 45551 It will empower consumers to make more informed decisions about the drugs they buy. They will be able to shop around for the best deals on medicines and weigh the alternatives with their doctors. But it will also stimulate the cannabis industry in a big way, because consumers will be given this decision-making power at the height of two critical events… Why It's a Critical Year for Cannabis Stocks First, 2019 is a huge year for marijuana stocks. The gradual legalization of cannabis is expected to produce gains up to 1,000% for some pot stock investors. Some are even comparing it to Silicon Valley in the '80s and '90s. THREE STATES just legalized marijuana, and these three stocks could potentially see a 1,000% boost. Click here to learn more… Second, we are in the height of America's battle with opioids, and doctors are now more careful prescribing them. For example, insurance claims for opioids from California state employees reportedly dropped 19% in 2018. The California Public Employees' Retirement System even counted a 73% drop in the number of new users prescribed more than a week's supply.